Table 2.
Ceramide nmol/mg |
Females | Males | ||||
---|---|---|---|---|---|---|
NGT | IGT | T2D | NGT | IGT | T2D | |
C14:0-Cer | 1.08 ± 0.23 | 0.89 ± 0.16 a | 1.15 ± 0.12 * | 0.81 ± 0.23 | 0.94 ± 0.19 | 0.92 ± 0.12 |
C16:0-Cer | 17.81 ± 3.4 | 19.49 ± 2.5 | 22.99 ± 3.1 a,* | 16.83 ± 3.50 | 19.25 ± 2.45 | 20.84 ± 3.71 a |
C18:1-Cer | 0.43 ± 0.09 | 0.40 ± 0.11 | 0.38 ± 0.08 | 0.33 ± 0.11 | 0.36 ± 0.10 | 0.35 ± 0.09 |
C18:0-Cer | 1.21 ± 0.22 | 1.52 ± 0.17 a | 1.80 ± 0.25 a,* | 1.42 ± 0.48 | 1.68 ± 0.32 | 1.86 ± 0.36 a |
C20:0-Cer | 1.46 ± 0.30 | 1.62 ± 0.43 | 1.80 ± 0.28 a | 1.48 ± 0.36 | 1.83 ± 0.33 a | 1.79 ± 0.35 |
C22:0-Cer | 15.11 ± 3.13 | 17.59 ± 2.47 | 20.48 ± 3.04 a | 14.87 ± 3.54 | 18.49 ± 3.59 a | 20.16 ± 2.67 a |
C24:1-Cer | 29.37 ± 6.01 | 31.20 ± 5.54 | 32.03 ± 6.49 | 29.48 ± 6.73 | 33.68 ± 5.64 | 35.85 ± 5.09 a |
C24:0-Cer | 22.40 ± 5.02 | 25.32 ± 4.55 | 27.74 ± 5.11 a | 24.25 ± 5.39 | 27.16 ± 3.49 | 29.59 ± 3.37 a |
Total Cer | 88.87 ± 14.46 | 98.02 ± 12.22 | 108.37 ± 9.73 a | 89.47 ± 17.17 | 103.41 ± 12.54 a | 111.36 ± 11.15 a |
Data expressed as mean ± standard deviation; NGT—normal glucose tolerance group; IGT—impaired glucose tolerance group; T2D—type 2 diabetes group; a p < 0.05 vs. NGT; * p < 0.05 vs. IGT.